Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
801.49
752.79
725.11
599.24
476.06
645.77
627.88
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
801.49
752.79
725.11
599.24
476.06
645.77
627.88
Raw Material Cost
575.74
524.60
516.34
424.15
338.01
445.20
432.17
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
150.91
132.84
123.38
102.84
93.70
143.94
130.70
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.32
2.76
5.24
3.24
1.71
3.27
3.38
Selling and Distribution Expenses
196.99
200.59
187.01
161.43
127.88
180.46
156.06
Other Expenses
-154.07
-134.47
-127.30
-103.15
-92.76
-143.13
-131.59
Total Expenditure (Excl Depreciation)
772.88
726.32
704.68
588.51
468.54
629.73
590.72
Operating Profit (PBDIT) excl Other Income
28.61
26.47
20.43
10.73
7.52
16.03
37.16
Other Income
89.51
61.37
47.39
17.75
17.31
8.14
7.30
Operating Profit (PBDIT)
125.52
100.05
79.68
40.67
37.37
37.61
58.22
Interest
3.32
2.76
5.24
3.24
1.71
3.27
3.38
Exceptional Items
-5.53
-0.12
0.00
-0.01
-0.02
-0.54
-0.92
Gross Profit (PBDT)
225.76
228.19
208.77
175.09
138.05
200.57
195.71
Depreciation
8.33
13.06
12.81
12.58
13.02
14.38
14.67
Profit Before Tax
108.33
84.12
61.64
24.84
22.62
19.42
39.26
Tax
26.67
21.28
16.97
6.33
-14.16
7.11
14.89
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
81.66
62.84
44.67
18.51
36.78
12.32
24.37
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
81.66
62.84
44.67
18.51
36.78
12.32
24.37
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
81.66
62.84
44.67
18.51
36.78
12.32
24.37
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
1,065.05
1,000.92
953.38
329.63
294.65
248.99
251.43
Earnings per share (EPS)
57.79
44.47
452.73
29.43
32.87
8.72
17.25
Diluted Earnings per share
57.79
44.47
452.73
29.43
32.87
8.72
17.25
Operating Profit Margin (Excl OI)
3.45%
3.4%
2.69%
1.73%
1.48%
2.34%
5.77%
Gross Profit Margin
14.56%
12.91%
10.27%
6.24%
7.49%
5.23%
8.59%
PAT Margin
10.19%
8.35%
6.16%
3.09%
7.73%
1.91%
3.88%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 6.47% vs 3.82% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 29.95% vs 40.68% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -6.90% vs 19.79% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 20.29% vs -47.33% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of TTK Healthcare With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
801.49
2,515.64
-1,714.15
-68.14%
Other Operating Income
0.00
0.00
0.00
Total Operating income
801.49
2,515.64
-1,714.15
-68.14%
Raw Material Cost
575.74
1,601.84
-1,026.10
-64.06%
Purchase of Finished goods
0
55.67
-55.67
-100.00%
(Increase) / Decrease In Stocks
0
-1.81
1.81
100.00%
Employee Cost
150.91
256.42
-105.51
-41.15%
Power Cost
0
0.00
0.00
Manufacturing Expenses
3.32
0.00
3.32
Selling and Distribution Expenses
196.99
0.00
196.99
Other Expenses
-154.07
290.94
-445.01
-152.96%
Total Expenditure (Excl Depreciation)
772.88
2,203.06
-1,430.18
-64.92%
Operating Profit (PBDIT) excl Other Income
28.61
312.58
-283.97
-90.85%
Other Income
89.51
50.03
39.48
78.91%
Operating Profit (PBDIT)
125.52
362.61
-237.09
-65.38%
Interest
3.32
26.53
-23.21
-87.49%
Exceptional Items
-5.53
0.00
-5.53
Gross Profit (PBDT)
225.76
336.08
-110.32
-32.83%
Depreciation
8.33
60.27
-51.94
-86.18%
Profit Before Tax
108.33
275.81
-167.48
-60.72%
Tax
26.67
80.99
-54.32
-67.07%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
81.66
194.82
-113.16
-58.08%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0.00
0.00
Other Adjustments
0
0.00
0.00
Net Profit
81.66
194.82
-113.16
-58.08%
Share in Profit of Associates
0
64.46
-64.46
-100.00%
Minority Interest
0.00
6.68
-6.68
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
81.66
265.96
-184.30
-69.30%
Equity Capital
0
171.00
-171.00
-100.00%
Face Value
10.00
10.00
0.00
Reserves
1,065.05
1,797.66
-732.61
-40.75%
Earnings per share (EPS)
57.79
15.55
42.24
271.64%
Diluted Earnings per share
57.79
15.55
42.24
271.64%
Operating Profit Margin (Excl OI)
3.45%
12.43%
0.00
-8.98%
Gross Profit Margin
14.56%
13.36%
0.00
1.20%
PAT Margin
10.19%
7.74%
0.00
2.45%
Public Share Holdings (%)
0%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 801.49 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.47% vs 3.82% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 81.66 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 29.95% vs 40.68% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 36.01 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.90% vs 19.79% in Mar 2024
Annual - Interest
Interest 3.32 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 20.29% vs -47.33% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.45%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024






